1. Resource Table.
| Unique stem cell identifier | FDCHDPe010-A-56 |
|---|---|
|
| |
| Alternative name(s) of stem cell line | LRP2-KO hESCs |
| Institution | Eye & ENT Hospital, Shanghai Medical School, Fudan University, Shanghai, China |
| Contact information of distributor | Jie You, 513yj45@163.com; |
| Ling Chen, linglingchen98@hotmail.com | |
| Type of cell line | ESC |
| Origin | Human |
| Additional origin info | Age: blastocyst stage Sex: female, 46, XX Ethnicity: N/A |
| Cell source | N/A |
| Clonality | Clonal |
| Method of reprogramming | N/A |
| Cell culture system used | mTeSR™1 |
| Genetic modification | Yes |
| Type of modification | Induced mutation |
| Associated disease | Endocytosis deficiency disease |
| Gene/locus | Gene:LRP2 Locus:2q31.1 |
| Method of modification | CRISPR/Cas9 |
| Site-specific nuclease (SSN) delivery method | Plasmid transfection |
| All genetic material introduced into the cells | Cas plasmid |
| Karyotyping | |
| Analysis of the nuclease- targeted allele status | |
| Method of the off-target nuclease activity surveillance | Targeted PCR/sequencing |
| Name of transgene or resistance | N/A |
| Inducible/constitutive system | Transient expression of Sacas9 and GFP under CMV promoter |
| Data archived/stock date | December 2020 |
| Cell line repository/bank | N/A |
| Ethical approval | This study was approved by the ethics committee of Fudan University affiliated Eye & ENT Hospital (KJ2011-04) |